A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma
| Image |  |
|---|---|
| Description | scientific article published on 23 June 2017 |
| Author/s |
author: Tatjana Stankovic Martin Dyer Christopher Fegan David Allsup Guy Pratt Christina Yap |
| Publication date | June 23, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |